Skip to main content
Premium Trial:

Request an Annual Quote

Horizon Discovery Edit-R CRISPRa crRNA Libraries

Horizon Discovery announced the introduction of its Edit-R CRISPR arrayed crRNA (CRISPR RNA) libraries, which offer a tool for drug discovery, pathway analysis and disease progression studies. The libraries allow one-gene-per-well investigation by using high-content assays. The Edit-R CRISPRa portfolio also includes catalogue libraries for human and mouse gene families, including ubiquitin enzymes, transcription factors, and kinases, in addition to druggable gene targets and the whole human genome. The firm also noted that researchers will also be able to use bespoke collections to target a specialized gene target list.  

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more